Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 436 M451 M466 M482 M471 M468 M 1.89 B Research & development —————— — Operating income 1.27 B1.96 B2.16 B1.6 B1.7 B1.99 B 7.45 B Non-Operating Income, Total —————— — Interest expense, net of interest capitalized 1.09 B1.06 B1.01 B973 M968 M975 M 3.93 B Non-Operating Income, excl. Interest Expenses —————— — Unusual income/expense —————— — Pretax income 984 M1.26 B1.43 B952 M1.05 B1.19 B 4.61 B Equity in earnings —————— — Taxes 227 M289 M352 M201 M242 M301 M 1.1 B Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 757 M967 M1.08 B751 M805 M885 M 3.52 B Discontinued operations —————— — Net income 757 M967 M1.08 B751 M805 M885 M 3.52 B Dilution adjustment 000000 0 Preferred dividends 21 M21 M20 M21 M21 M21 M 83 M Diluted net income available to common stockholders 736 M946 M1.06 B730 M784 M864 M 3.44 B Basic earnings per share (Basic EPS) 1.912.512.892.072.292.61 9.86 Diluted earnings per share (Diluted EPS) 1.892.52.862.032.272.59 9.75 Average basic shares outstanding 385.2 M376.2 M365.9 M369.9 M342.4 M331.3 M — Diluted shares outstanding 389.4 M379.1 M369.9 M373.9 M346 M334.1 M — EBITDA 234 M953 M1.21 B687 M802 M1.04 B 3.74 B EBIT 109 M831 M1.08 B548 M659 M900 M 3.19 B Cost of revenue 1.49 B1.15 B1.15 B1.44 B1.33 B1.2 B 5.12 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 125 M122 M128 M139 M143 M145 M 555 M